Crossmark

Advancing EGFR-targeted anticancer strategies: the potential of thiazole, pyrazole, and thiazole–pyrazole hybrids

Crossref DOI link: https://doi.org/10.1186/s43094-025-00893-5

Published Online: 2025-10-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sanas, Prerana https://orcid.org/0009-0006-5043-2591
Chitre, Trupti
License Information

Text and Data Mining valid from 2025-10-08

Version of Record valid from 2025-10-08
More Information

Article History

Received: 23 July 2024

Accepted: 30 September 2025

First Online: 8 October 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.